|
|
|
Careers
|
Contact Us
Home
About us
Pipeline
Partnering
News / Events
Investors
Investor Home
Share Performance
News and Events
Financials
Analyst coverage
SEC filings
Corporate Governance
Information Request
Investor Tools
Print Page
E-mail Page
RSS Feeds
E-mail Alerts
IR Contacts
SEC Filings
Form 6-K
BIOLINERX LTD. filed this
Form 6-K
on 07/30/2018
Document Outline
Entire Document (38.3 KB)
Subdocument 1 - 6-K - 6-K
Page 1 - SECURITIES AND EXCHANGE COMMISSION
Page 2 - N/A
Page 3 - N/A
Subdocument 2 - EX-99 - PRESS RELEASE
Page 1 - Exhibit 1
Page 2 - About the COMBAT/KEYNOTE-202 Study
Page 3 - About BL-8040
Page 4 - Various statements in this release concerning BioLineRx s future expectations constitute forward-loo
Interview with Philip Serlin, CEO
December 2016
Copyright © 2010 BioLineRx. All rights reserved |
Terms of Use
|
Privacy Policy
Web Design by: XG Media
|
Web Development : imoon
